MENU
APUS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Apimeds Pharmaceuticals US (APUS) Ownership - Who owns Apimeds Pharmaceuticals US?
Apimeds Pharmaceuticals Us Inc is a clinical-stage company... Show more
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
23.14M
P/E Ratio
N/A
Total Cash
8.74M
Projected Growth
N/A
Total Debt
500K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.69
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APUS
Capitalization
23.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
8.74M
Total Cash/Share
0.69
Total Debt
500K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.74M
P/B Ratio
2.38
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
126K
Current Ratio
12.79
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-69.84
Shares Held By Institutions
55.5K
Shares Outstanding - Current
12.6M
Total Liabilities
809K
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information